This inventor holds 1 USPTO granted patent. Top assignee: Taejoon Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hyun Won Seo: Innovator in Ophthalmic Compositions
Introduction
Hyun Won Seo is a notable inventor based in Jeonju-si, South Korea. He has made significant contributions to the field of ophthalmology through his innovative work in nanoemulsion compositions. His research focuses on improving ocular treatments, particularly for conditions that cause discomfort and irritation.
Latest Patents
Hyun Won Seo holds a patent for a "Nanoemulsion ophthalmic composition comprising cyclosporine and menthol, and preparation method thereof." This invention relates to a nanoemulsion ophthalmic composition that is created by mixing cyclosporine, castor oil, hydrophilic and hydrophobic emulsifiers, menthol, and an aqueous solvent. The resulting composition exhibits excellent stability and effectively alleviates ocular irritation, including symptoms such as grittiness and blurry vision. He has 1 patent to his name.
Career Highlights
Hyun Won Seo is currently associated with Taejoon Pharmaceutical Co., Ltd., where he continues to develop innovative solutions in the pharmaceutical industry. His work is instrumental in advancing treatments that enhance patient comfort and care.
Collaborations
He collaborates with talented colleagues, including Joon Youb Lee and Youn Jae Shin, who contribute to the research and development efforts at Taejoon Pharmaceutical Co., Ltd.
Conclusion
Hyun Won Seo's contributions to ophthalmic compositions highlight his commitment to improving eye care through innovation. His work not only addresses critical issues in ocular health but also sets a foundation for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile